You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 6, February 12, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vascular Access in Patients Receiving Hemodialysis

Nauman Qureshi, MD
Athens, Ala

JAMA. 1997;277(6):455.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The increasing use of arteriovenous (AV) grafts compared with fistulas in the United States reported by Dr Hirth and colleagues1 is all the more surprising given the increased availability of a dialysis catheter with the subcutaneous tunnel (Perm catheter, Quinton, Seattle, Wash). Fistulas generally require 6 to 12 weeks to "mature," which is 3 to 4 times longer than grafts.2 Dialysis is needed during the interim, especially among the late-referred patients. A tunneled catheter is preferable for longer-term "temporary" access. The increased availability of this type of catheter between 1986 and 1990 would presumably have allowed the permanent access more time to mature and, hence, would have favored arteriovenous fistula (AVF) placement over AV graft placement.

In addition, Hirth et al1 mention that in Japan 100% of patients newly treated with hemodialysis receive a fistula as their first method of access. Is there a . . . [Full Text PDF of this Article]


Footnotes

Edited by Margaret A. Winker, MD, Senior Editor, and Phil B. Fontanarosa, MD, Senior Editor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.